Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Plos One|April 19, 2012
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-METSameer A Greenall, Ermanno Gherardi, Zhanqi Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitopeKosei Hasegawa, Yuji Noguchi, Fumihito Koizumi, et al.Cancer Science|December 18, 2007
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogelShinichi Kageyama, Shigehisa Kitano, Michiko Hirayama, et al.Cancer Immunology, Immunotherapy : CII|March 4, 2008
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patientKazuhide Tsuji, Toshitada Hamada, Akiko Uenaka, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2014
Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabineRebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, et al.International Journal of Cancer|February 6, 2007
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patientsRyohei Kawabata, Hisashi Wada, Midori Isobe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulanShigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, et al.International Journal of Cancer|August 30, 2008
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccinationHisashi Wada, Eiichi Sato, Akiko Uenaka, et al.Cancer Immunity|April 20, 2007
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 proteinAkiko Uenaka, Hisashi Wada, Midori Isobe, et al.International Journal of Cancer|March 18, 2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccinationJunji Kawada, Hisashi Wada, Midori Isobe, et al.Pageof 3